Search research articles
Contact Us
Filters
Showing results (121-130 of 147) with videos related to
Page
of 15
Sort By:
Thrombosis and Haemostasis
|
January 4, 2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
JACC. Basic to Translational Science
|
August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
Pharmacogenomics
|
March 28, 2017
Institutional profile: University of Florida Health Personalized Medicine Program
Larisa H Cavallari, Kristin W Weitzel, Amanda R Elsey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 18, 2020
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection
Amber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 5, 2020
Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection
Amber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Clinical Pharmacology and Therapeutics
|
August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants
Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Nature Reviews. Cardiology
|
July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Journal of the American Heart Association
|
July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy
Rajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
JACC. Basic to Translational Science
|
January 31, 2020
Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study
Francesco Franchi, Fabiana Rollini, Victor Kairouz, et al.
Clinical and Translational Science
|
July 10, 2026
Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI
Caroline W Grant, Brenden S Ingraham, Ryan J Lennon, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 147) with videos related to
Sort By:
Page
of 15
Thrombosis and Haemostasis
|
January 4, 2022
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease
Mattia Galli, Francesco Franchi, Fabiana Rollini, et al.
JACC. Basic to Translational Science
|
August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
Pharmacogenomics
|
March 28, 2017
Institutional profile: University of Florida Health Personalized Medicine Program
Larisa H Cavallari, Kristin W Weitzel, Amanda R Elsey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 18, 2020
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection
Amber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 5, 2020
Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection
Amber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Clinical Pharmacology and Therapeutics
|
August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants
Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Nature Reviews. Cardiology
|
July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Journal of the American Heart Association
|
July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy
Rajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
JACC. Basic to Translational Science
|
January 31, 2020
Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study
Francesco Franchi, Fabiana Rollini, Victor Kairouz, et al.
Clinical and Translational Science
|
July 10, 2026
Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCI
Caroline W Grant, Brenden S Ingraham, Ryan J Lennon, et al.
Page
of 15